Delhi's Covid-19 vaccine stock to last for eight days: Bulletin

The stock of Coronavirus vaccine in the national capital will last for another eight days, according to a vaccination bulletin issued by the Delhi government on Monday

vaccination
Photo: Bloomberg
Press Trust of India New Delhi
1 min read Last Updated : Sep 06 2021 | 8:49 PM IST

The stock of Coronavirus vaccine in the national capital will last for another eight days, according to a vaccination bulletin issued by the Delhi government on Monday.

As of Monday morning, 1,61,450 doses of Covaxin and 12,46,420 doses of Covishield are left in stock.

The bulletin noted that 5,43,550 doses of Covishield were added to the stock on Sunday.

In all, the Delhi government has received 1,39,41,230 vaccine doses till date, out of which, 31,20,660 doses were of Covaxin and the remaining Covishield.

The city has administered 1,41,04,324 doses of vaccine, including those given at private facilities, out of which, 1,00,43,341 were first doses and 40,60,983 second jabs.

On Sunday, 8,353 vaccine doses were administered. Of these, 2,291 were first doses and 6,062 were second ones, the bulletin said.

Delhi's current vaccination capacity is 2,23,141 doses per day, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelhiVaccination

First Published: Sep 06 2021 | 8:49 PM IST

Next Story